FDS · Insider Trading
Factset Research Systems
Every open-market purchase and sale reported by FDS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-19 | Robin Ann Abrams | Director | G | −375 | — |
| 2026-09-25 | Gregory T Moskoff | MD,Controller and CAO | A | +97 deriv. | — |
| 2026-09-24 | Sanoke Viswanathan | Chief Executive Officer | F | −8,065 | −$2.23M |
| 2026-05-05 | Joshua Warren | EVP, Chief Financial Officer | A | +2,272 | — |
| 2026-02-17 | Gregory T Moskoff | MD,Controller and CAO | MIXED | +13 | −$2.63K |
| 2026-01-20 | Malcolm Frank | Director | A | +713 | — |
| 2026-01-20 | Laurie Siegel | Director | A | +626 | — |
| 2026-01-20 | Robin Ann Abrams | Director | A | +604 | — |
| 2026-01-20 | Barak Eilam | Director | A | +439 | — |
| 2026-01-20 | Maria Teresa Tejada | Director | A | +439 | — |
| 2026-01-20 | Siew Kai Choy | Director | A | +439 | — |
| 2026-01-20 | Shlomo Elisha Wiesel | Director | A | +571 | — |
| 2026-01-20 | Lee Shavel | Director | A | +571 | — |
| 2026-01-20 | Laurie G Hylton | Director | A | +439 | — |
| 2026-01-14 | Malcolm Frank | Director | MIXED | — | −$225.88K |
| 2026-01-12 | Laurie Siegel | Director | MIXED | — | −$227.28K |
| 2026-01-08 | Robin Ann Abrams | Director | M | +2,572 | +$534.67K |
| 2025-12-03 | Christopher McLoughlin | Chief Legal Officer | F | −731 | −$203.42K |
| 2025-11-10 | Goran Skoko | EVP, Chief Revenue Officer | Buy | +500 | +$126.47K |
| 2025-11-05 | Katherine M Stepp | Chief Technology Officer (CTO) | A | +6,969 deriv. | — |
| 2025-11-05 | Christopher R Ellis | EVP, Initiatives & P'ships | A | +3,982 deriv. | — |
| 2025-11-05 | Christopher McLoughlin | Chief Legal Officer | A | +5,310 deriv. | — |
| 2025-11-05 | Robert J. Robie | EVP, Institutional Buyside | A | +8,296 deriv. | — |
| 2025-11-05 | Gregory T Moskoff | MD,Controller and CAO | A | +2,157 deriv. | — |
| 2025-11-05 | Kristina W Karnovsky | EVP, Dealmakers & Wealth | A | +8,296 deriv. | — |
| 2025-11-05 | John Costigan | Chief Data Officer | A | +3,915 | — |
| 2025-11-05 | Goran Skoko | EVP, Chief Revenue Officer | A | +3,915 | — |
| 2025-11-05 | Helen L. Shan | EVP, Chief Financial Officer | A | +14,933 deriv. | — |
| 2025-11-05 | Catrina Harding | Chief People Officer | A | +5,973 deriv. | — |
| 2025-11-03 | Kristina W Karnovsky | EVP, Dealmakers & Wealth | MIXED | +253 | −$67.23K |
| 2025-11-03 | Goran Skoko | EVP, Chief Revenue Officer | MIXED | +323 | −$77.11K |
| 2025-11-03 | Robert J. Robie | EVP, Institutional Buyside | MIXED | +253 | −$67.23K |
| 2025-11-03 | John Costigan | Chief Data Officer | MIXED | +245 | −$32.55K |
| 2025-11-03 | Katherine M Stepp | Chief Technology Officer (CTO) | MIXED | +196 | −$45.62K |
| 2025-11-03 | Gregory T Moskoff | MD,Controller and CAO | MIXED | +101 | −$23.75K |
| 2025-11-03 | Helen L. Shan | EVP, Chief Financial Officer | MIXED | +451 | −$148.87K |
| 2025-11-03 | Christopher R Ellis | EVP, Initiatives & P'ships | MIXED | +188 | −$43.76K |
| 2025-10-08 | Helen L. Shan | EVP, Chief Financial Officer | Buy | +370 | +$101.93K |
| 2025-10-07 | Barak Eilam | Director | Sell | −1 | −$283 |
| 2025-09-25 | Christopher McLoughlin | Chief Legal Officer | Buy | +337 | +$100.00K |
| 2025-09-24 | Sanoke Viswanathan | Chief Executive Officer | A | +58,332 | — |
| 2025-09-17 | Gregory T Moskoff | MD,Controller and CAO | A | +190 deriv. | — |
| 2025-09-17 | Helen L. Shan | EVP, Chief Financial Officer | A | +1,009 deriv. | — |
| 2025-09-17 | Goran Skoko | EVP, Chief Revenue Officer | A | +612 deriv. | — |
| 2025-09-17 | Robert J. Robie | EVP, Institutional Buyside | A | +505 deriv. | — |
| 2025-09-17 | Christopher R Ellis | EVP, Initiatives & P'ships | A | +352 deriv. | — |
| 2025-09-17 | Kristina W Karnovsky | EVP, Dealmakers & Wealth | A | +505 deriv. | — |
| 2025-09-17 | Katherine M Stepp | Chief Technology Officer (CTO) | A | +367 deriv. | — |
| 2025-09-17 | John Costigan | Chief Data Officer | A | +367 deriv. | — |
| 2025-08-05 | Catrina Harding | Chief People Officer | F | −302 | −$118.18K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Sanoke Viswanathan | Chief Executive Officer | 50,267 | $16.68M |
| Christopher R Ellis | EVP, Initiatives & P'ships | 24,655 | $8.18M |
| Frederick Philip Snow | Chief Executive Officer | 19,616 | $6.51M |
| Robin Ann Abrams | Director | 15,365 | $5.10M |
| James J McGonigle | Director | 14,238 | $4.72M |
| Helen L. Shan | EVP, Chief Financial Officer | 10,293 | $3.42M |
| Goran Skoko | EVP, Chief Revenue Officer | 9,191 | $3.05M |
| John Costigan | Chief Data Officer | 4,478 | $1.49M |
| Kristina W Karnovsky | EVP, Dealmakers & Wealth | 2,787 | $924.82K |
| Christopher McLoughlin | Chief Legal Officer | 2,714 | $900.66K |
| Robert J. Robie | EVP, Institutional Buyside | 2,303 | $764.09K |
| Joshua Warren | EVP, Chief Financial Officer | 2,272 | $753.80K |
| Laurie Siegel | Director | 1,663 | $551.75K |
| Malcolm Frank | Director | 1,592 | $528.19K |
| Lee Shavel | Director | 1,587 | $526.53K |
| Siew Kai Choy | Director | 1,442 | $478.43K |
| Maria Teresa Tejada | Director | 1,415 | $469.47K |
| Shlomo Elisha Wiesel | Director | 1,141 | $378.56K |
| Katherine M Stepp | Chief Technology Officer (CTO) | 979 | $324.87K |
| Laurie G Hylton | Director | 848 | $281.35K |
| Barak Eilam | Director | 724 | $240.21K |
| Catrina Harding | Chief People Officer | 458 | $151.96K |
| Gregory T Moskoff | MD,Controller and CAO | 180 | $59.98K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the FDS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.